The Valley Desk

NCT01752920 · Interventional trial

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Overall registry status Completed

Phase 1 · Phase 2

Conditions Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov